INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo SCORBEX® 100 TABLETS
SCORBEX® 250 TABLETS
SCORBEX® 500 TABLETS

SCHEDULING STATUS:
Not Scheduled.

PROPRIETARY NAME
(and dosage form):

SCORBEX® 100 TABLETS
SCORBEX® 250 TABLETS
SCORBEX® 500 TABLETS

COMPOSITION:
Tablets containing 100 mg, 250 mg or 500 mg
Ascorbic Acid (Vitamin C).

PHARMACOLOGICAL CLASSIFICATION:
A 22.1.4 Vitamins - other.

PHARMACOLOGICAL ACTION:
Vitamin C is a vitamin supplement.

INDICATIONS:
For the prevention of and treatment of vitamin C deficiency.

WARNING:
KEEP OUT OF REACH OF CHILDREN.

DOSAGE AND DIRECTIONS FOR USE:
100 mg:
        Take one tablet three times a day, after meals, or as prescribed.
250 mg:        Take one tablet three times a day, after meals, or as prescribed.
500 mg:        Take one tablet twice a day, after meals, or as prescribed.

SIDE EFFECTS AND SPECIAL PRECAUTIONS:
Large doses may cause excessive urination, diarrhoea, other gastro-intestinal disturbances, and the formation of renal calcium oxalate calculi. Acidification of the urine by ascorbic acid may cause precipitation of cystine or oxalate stones in the urinary tract and will alter the excretion of certain drugs administered concurrently. Very large doses of Vitamin C, therefore, should be avoided in patients with tendency to gout. Tolerance may in induced in patients taking high doses. Ascorbic acid in doses greater than 1 g daily should not be taken during pregnancy since the effects of large doses on the foetus is unknown and may cause rebound scurvy in infants.
Interference with biochemical laboratory tests:
Ascorbic acid could cause chemical interference in laboratory tests for blood or urine creatinine, glucose and uric acid. It is therefore advisable not to take Vitamin C prior to such tests being performed.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Amounts of up to 10 grams may cause diarrhoea. Fluid and electrolyte replacement therapy should be instituted if necessary.
Treatment is supportive and symptomatic.

IDENTIFICATION:
Plain white, biconvex, bisected tablets.

PRESENTATION:
100 mg Tablets:
        Packs of 100, 500 and 1000 tablets.
250 mg Tablets:        Packs of 50 and 100 tablets.
500 mg Tablets:        Packs of 40, 100 and 5000 tablets.

STORAGE INSTRUCTIONS:
Store below 25°C. Protect from light and moisture.
KEEP OUT OF REACH OF CHILDREN.

APPLICATION NUMBER:
100 mg:
        H 2055 (Act 101/1965)
250 mg:        H 2056 (Act 101/1965)
500 mg:        H 2057 (Act 101/1965)

NAME AND BUSINESS ADDRESS OF APPLICANT:
PHARMACARE LIMITED
7 Fairclough Road
Korsten, PORT ELIZABETH 6020

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
December 1974

Code 308036 A63                        LH&SEL-K16619 G97

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996,1997,1998